Literature DB >> 7800359

Herpes zoster ophthalmicus in Malawi.

S Lewallen1.   

Abstract

OBJECTIVE: The objective was to describe the complications and outcomes of herpes zoster ophthalmicus in a population of young Africans with a high seroprevalence of human immunodeficiency virus type 1 in which treatment often is delayed and in which antiviral drugs are not available.
METHODS: Twenty-seven patients with herpes zoster ophthalmicus presenting consecutively to a large urban hospital were examined and followed. Treatment was limited to that which was locally available.
RESULTS: Visual outcomes were poor. Sixty-six percent of eyes had final visual acuity less than 20/60. Forty percent had light perception or no light perception visual acuity. Severe keratouveitis and corneal perforation were common and responsible for most poor visual outcomes.
CONCLUSION: Young Africans with herpes zoster ophthalmicus are at a high risk for significant visual loss.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7800359     DOI: 10.1016/s0161-6420(94)31099-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  5 in total

Review 1.  Blindness in Africa: present situation and future needs.

Authors:  S Lewallen; P Courtright
Journal:  Br J Ophthalmol       Date:  2001-08       Impact factor: 4.638

2.  HIV- and AIDS-related Ocular Manifestations in Tanzanian Patients.

Authors:  Soumendra Sahoo
Journal:  Malays J Med Sci       Date:  2010-01

3.  [Tropical ophthalmology--prevention and therapy"Vision 2020--the right to sight"].

Authors:  V Klauss; U C Schaller
Journal:  Ophthalmologe       Date:  2004-06-16       Impact factor: 1.059

4.  Prognostic value of Hutchinson's sign in acute herpes zoster ophthalmicus.

Authors:  Michel J W Zaal; Hennie J Völker-Dieben; Joe D'Amaro
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-02-11       Impact factor: 3.535

5.  Predictors of HIV/AIDS Related Ocular Manifestations among HIV/AIDS Patients in Felege Hiwot Referral Hospital, Northwest Ethiopia.

Authors:  Guadie Sharew; Muluken Azage
Journal:  J Ophthalmol       Date:  2015-04-27       Impact factor: 1.909

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.